M. Shirahata

发表

Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis

N. Hashimoto, M. Shirahata, Kyoko Iwao-Koizumi, 2007, Clinical Cancer Research.

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

E. Miyaoka, Hideo Nakamura, T. Maehara, 2016, Acta neuropathologica communications.

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

David T. W. Jones, D. Louis, R. Stupp, 2018, Acta Neuropathologica.

Using gene expression profiling to identify a prognostic molecular spectrum in gliomas

S. Ishii, N. Hashimoto, M. Shirahata, 2008, Cancer science.

Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy

N. Hashimoto, M. Shirahata, J. Takahashi, 2008, Journal of Neuro-Oncology.

Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors

K. Ichimura, M. Shirahata, K. Mishima, 2022, Brain Tumor Pathology.

True anaplastic oligoastrocytoma with dual genotype: illustrative case

M. Shirahata, K. Mishima, R. Nishikawa, 2022, Journal of neurosurgery. Case lessons.

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report

N. Nonoguchi, S. Miyatake, T. Kuroiwa, 2017, Neurologia medico-chirurgica.

GERM CELL TUMOURS

Dong Seok Kim, Teo Wan Yee, R. Gibbs, 2014, The Ulster Medical Journal.

Intraventricular Hemorrhage From a Glioblastoma in the Medulla Oblongata of an Adolescent: A Potential Diagnostic Pitfall.

M. Shirahata, H. Toda, K. Iwasaki, 2015, Pediatric neurology.

Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region

S. Miyamoto, Y. Kukita, M. Shirahata, 2014, BMC Cancer.

Clinical significance and pitfalls of human chorionic gonadotropin-related tumor markers for intracranial germinomas.

M. Shirahata, K. Mishima, R. Nishikawa, 2023, Child's Nervous System.

Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance: assessment by using a highly sensitive enzyme immunoassay.

M. Shirahata, K. Mishima, R. Nishikawa, 2016, Journal of neurosurgery. Pediatrics.

Intrathecal and intraperitoneal germinomas occurring 20 years after total removal of a pineal teratoma. Case report.

J. Jito, M. Shirahata, Y. Hirose, 2002, Journal of neurosurgery.

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

Stefan M. Pfister, Damian Stichel, Felix Sahm, 2018, Acta Neuropathologica.

Genomic characterization of primary central nervous system lymphoma

H. Aburatani, H. Ueda, M. Soda, 2016, Acta Neuropathologica.

Endogenous tenascin‐C enhances glioblastoma invasion with reactive change of surrounding brain tissue

N. Hashimoto, M. Shirahata, J. Takahashi, 2009, Cancer science.

Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing

D. Louis, A. von Deimling, M. Shirahata, 2018, Seminars in Neurology.

Primary intramedullary spinal cord pilocytic astrocytoma with anaplasia in an adult: illustrative case

M. Takayama, M. Shirahata, J. Adachi, 2022, Journal of neurosurgery. Case lessons.

Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma

M. Shirahata, K. Mishima, R. Nishikawa, 2021, Brain Tumor Pathology.

An epidermoid cyst of the thoracic spine in an elderly patient: case report.

M. Shirahata, K. Mishima, R. Nishikawa, 2019, World neurosurgery.

Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence

M. Shirahata, K. Mishima, R. Nishikawa, 2021, Brain Tumor Pathology.

Temozolomide Treatment for Pediatric Refractory Anaplastic Ependymoma with Low MGMT Protein Expression

K. Ichimura, M. Shirahata, Tomohiko Nakamura, 2016, Pediatric blood & cancer.

Quantitative analysis of topoisomerase IIalpha to rapidly evaluate cell proliferation in brain tumors.

N. Hashimoto, M. Shirahata, M. Oda, 2005, Biochemical and biophysical research communications.

Brainstem oligodendroglial tumors in children: two case reports and review of literatures

M. Shirahata, K. Mishima, R. Nishikawa, 2015, Child's Nervous System.

Malignant transformation of germinoma 14 years after onset: Favorable efficacy of oral etoposide

M. Shirahata, K. Mishima, R. Nishikawa, 2015, Pediatrics international : official journal of the Japan Pediatric Society.

Duration between onset and diagnosis in central nervous system tumors: Impact on prognosis and functional outcome

M. Shirahata, K. Mishima, R. Nishikawa, 2014, Pediatrics international : official journal of the Japan Pediatric Society.

Conversion of a molecular classifier obtained by gene expression profiling into a classifier based on real-time PCR: a prognosis predictor for gliomas

N. Hashimoto, S. Miyamoto, Y. Kukita, 2010, BMC Medical Genomics.

Transient ischemic attack due to dissection of the middle cerebral artery--case report.

J. Jito, M. Shirahata, Y. Tokuriki, 2001, Neurologia medico-chirurgica.

Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region

Y. Kukita, M. Shirahata, Kikuya Kato, 2014, BMC Cancer.

Conversion of a molecular classifier obtained by gene expression profiling into a classifier based on real-time PCR: a prognosis predictor for gliomas

N. Hashimoto, S. Miyamoto, Y. Kukita, 2010, BMC medical genomics.

A SHORT TEXTBOOK OF MEDICINE

Dong Seok Kim, Teo Wan Yee, R. Gibbs, 1973, The Ulster Medical Journal.